SHCAY
Sharp Corporation·Technology
0.90
0.290%(+0.00)
Market ClosedLast Updated: — ET
52W L: $0.8152W H: $1.59
SHCAY NEWS
newsfilecorp.com
1d ago
Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term non-GLP testing the company has decided to advance an alternative compound for its Gaucher and GBA1 Parkinson's programs. The company continues to advance all platform programs including programs for genetic and sporadic forms of neurodegeneration (Progranulin modulators), and a rare neurodegenerative lysosomal disease (Niemann Pick Type C).
newsfilecorp.com
1d ago
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Fourth Tranche, the Company issued a total of 200 Notes for aggregate gross proceeds of approximately US$200,000.
newsfilecorp.com
Apr 2
Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 2, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the third tranche (the "Third Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Third Tranche, the Company issued a total of 200 Notes for aggregate gross proceeds of approximately US$200,000.
barrons.com
Apr 1
Cal-Maine Foods Posts Sharp Drop in Sales. The Stock Is Rising Anyway.
Falling egg prices hurt the egg producer's top and bottom lines in the third quarter.
247wallst.com
Mar 23
Investor Fear Just Got “Extreme.” These Oversold Stocks Might Be Due for a Sharp Rebound
The Fear and Greed Index is worth checking in on at moments like this, when the S&P 500 is on the verge of a correction.
youtube.com
Mar 20
Gold & Silver "Generational Opportunity" in Sharp Pullback?
With gold about $1,000 from highs and silver $50 off its high, David Stryzewski calls the current metal pullback an "opportunity." That opportunity extends to miners as well, with David calling what he considers low P/E ratios for companies.
